Weis, M <br/><br/>
Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation.  [electronic resource] 

 -  Journal of the American College of Cardiology  Sep 2001 
 - 814-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/s0735-1097(01)01430-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Coronary Angiography<br/>Cytokines--blood<br/>Endothelium, Vascular--drug effects<br/>Heart--drug effects<br/>Heart Transplantation--physiology<br/>Hemodynamics<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Hypercholesterolemia--complications<br/>Interleukin-2--blood<br/>Interleukin-6--blood<br/>Middle Aged<br/>Simvastatin--therapeutic use<br/>Tumor Necrosis Factor-alpha--analysis